Aqua Bio Technology 過去の業績

この会社の最新の決算報告書はまだ処理中です

過去基準チェック /06

Aqua Bio Technologyは93.2%の年平均成長率で業績を伸ばしているが、Chemicals業界はgrowingで7.1%毎年増加している。売上は成長しており、年平均664.1%の割合である。

主要情報

93.2%

収益成長率

93.4%

EPS成長率

Chemicals 業界の成長	32.6%
収益成長率	664.1%
株主資本利益率	-19.6%
ネット・マージン	-10.9%
次回の業績アップデート	12 Feb 2025

Recent updates

The Director of Aqua Bio Technology ASA (OB:ABT), Roger Hofseth, Just Bought A Few More Shares

Jan 20

Have Insiders Been Buying Aqua Bio Technology ASA (OB:ABT) Shares?

Dec 30

収支内訳

Aqua Bio Technology の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。

収益と収入の歴史

OB:ABTEC 収益、費用、利益 ( )NOK Millions
日付	収益	収益	G+A経費
30 Jun 23	14	-2	20
31 Mar 23	10	-10	18
31 Dec 22	7	-19	17
30 Sep 22	4	-20	18
30 Jun 22	2	-22	18
31 Mar 22	2	-21	18
31 Dec 21	2	-19	18
30 Sep 21	2	-18	17
30 Jun 21	1	-18	17
31 Mar 21	1	-16	16
31 Dec 20	1	-15	16
30 Sep 20	1	-13	14
30 Jun 20	1	-11	12
31 Mar 20	1	-12	12
31 Dec 19	1	-13	13
30 Sep 19	1	-26	14
30 Jun 19	1	-38	16
31 Mar 19	1	-38	16
31 Dec 18	1	-38	17
30 Sep 18	1	-30	17
30 Jun 18	2	-22	18
31 Mar 18	6	-19	20
31 Dec 17	10	-16	22
30 Sep 17	22	-6	22
30 Jun 17	33	-4	23
31 Mar 17	41	-3	28
31 Dec 16	49	1	29
30 Sep 16	47	5	27
30 Jun 16	46	13	27
31 Mar 16	42	17	20
31 Dec 15	39	17	17
30 Sep 15	34	11	17
30 Jun 15	30	10	15
31 Mar 15	26	5	16
31 Dec 14	22	1	16
30 Sep 14	21	-2	17
30 Jun 14	19	-4	17
31 Mar 14	21	0	15
31 Dec 13	23	3	14

質の高い収益: ABTECは現在利益が出ていません。

利益率の向上: ABTECは現在利益が出ていません。

フリー・キャッシュフローと収益の比較

過去の収益成長分析

収益動向: ABTECの過去 5 年間の前年比収益成長率がプラスであったかどうかを判断するにはデータが不十分です。

成長の加速: ABTECの過去 1 年間の収益成長を 5 年間の平均と比較することはできません。現在は利益が出ていないためです。

収益対業界: ABTECは利益が出ていないため、過去 1 年間の収益成長をChemicals業界 ( -5.7% ) と比較することは困難です。

株主資本利益率

高いROE: ABTECは現在利益が出ていないため、自己資本利益率 ( -19.57% ) はマイナスです。

Aqua Bio Technology 過去の業績

過去 基準チェック /06

主要情報

最近の業績更新

Aqua Bio Technology ASA to Report Q4, 2024 Results on Feb 12, 2025

Aqua Bio Technology ASA to Report Fiscal Year 2020 Results on Apr 14, 2021

Recent updates

New major risk - Share price stability

Aqua Bio Technology ASA Announces CEO Changes, Effective December 1, 2024

Aqua Bio Technology ASA (OB:ABTEC) completed the acquisition of 3d Innovation Nordic As from Coc Invest AS.

New major risk - Financial data availability

New major risk - Share price stability

Aqua Bio Technology ASA to Report Q4, 2024 Results on Feb 12, 2025

New minor risk - Financial data availability

Aqua Bio Technology ASA has filed a Follow-on Equity Offering in the amount of NOK 5 million.

Aqua Bio Technology ASA has completed a Follow-on Equity Offering in the amount of NOK 12.457015 million.

Aqua Bio Technology ASA (OB:ABTEC) entered into a share purchase agreement to acquire Cover Brands As from Medvind Holding As for NOK 16.5 million.

New major risk - Shareholder dilution

Aqua Bio Technology Asa Receives European Patent for Use of Chaga in Cosmetic Formulations

New minor risk - Shareholder dilution

Aqua Bio Technology ASA announced that it has received NOK 75.999999 million in funding

New major risk - Share price stability

Aqua Bio Technology ASA announced that it expects to receive NOK 76 million in funding

Aqua Bio Technology ASA (OB:ABTEC) entered into a binding agreement in principle to acquire SkinTeam Norge AS for NOK 45 million.

Aqua Bio Technology ASA Provides Earnings Guidance for the Full Year 2023

Aqua Bio Technology ASA, Annual General Meeting, Apr 28, 2023

No independent directors

Aqua Bio Technology ASA (OB:ABT) acquired Cosmed Beauty AS and Ultrabody AB from Varming Holding As.

Aqua Bio Technology ASA (OB:ABT) entered into a binding term sheet to acquire Cosmed Beauty AS and Ultrabody AB from Varming Holding As.

Aqua Bio Technology ASA (OB:ABT) entered into a binding term sheet to acquire Cosmed Beauty AS and Ultrabody AB from Varming Holding As.

No independent directors

Aqua Bio Technology ASA Announces Hydrafacial Launches Products Containing Aquabeautine XL in the UK

Chief Executive Officer recently bought kr55k worth of stock

Insider recently sold kr1.9m worth of stock

Director recently bought kr57m worth of stock

Aqua Bio Technology ASA Announces Strategic Partnership with DCP Dermoscience

Aqua Bio Technology ASA Signs Exclusive Distribution Agreement with Moana Active Skincare Limited for New Zealand and Australia

Aqua Bio Technology ASA Signs an Distribution Agreement with Galaxa Pharma Aps

Aqua Bio Technology ASA Signs Exclusive Distribution Agreement with Cosmed Beauty AS

Aqua Bio Technology ASA to Report Fiscal Year 2020 Results on Apr 14, 2021

New 90-day high: kr9.20

The Director of Aqua Bio Technology ASA (OB:ABT), Roger Hofseth, Just Bought A Few More Shares

Director recently bought kr141k worth of stock

Have Insiders Been Buying Aqua Bio Technology ASA (OB:ABT) Shares?

Aqua Bio Technology ASA Announces Completion and Approval of Safety Studies of 6 Products from the Product Series Balance & Vitality

Aqua Bio Technology Asa: Hydrafacial Has Entered into Partnership with Restorsea - Conversion Lab Launches Veritas Md Platform

Aqua Bio Technology ASA (OB:ABT) completed the acquisition of distribution of Moana Skincare from Limited Liability Company Management Company AB GROUP.

Aqua Bio Technology ASA Expects to Enter into Three-Year Agreement for the Distribution of Moana Products in New Zealand and Australia

Aqua Bio Technology ASA Announces Completion and Approval of Safety Studies by Nordic Beauty

Aqua Bio Technology ASA has completed a Follow-on Equity Offering in the amount of NOK 2.526 million.

New 90-day high - kr8.35

収支内訳

収益と収入の歴史

フリー・キャッシュフローと収益の比較

過去の収益成長分析

株主資本利益率

総資産利益率

使用総資本利益率

過去の好業績企業の発掘

過去基準チェック /06